In this study, we utilized bioinformatics methods to analyze multiple datasets, confirming the expression changes of GPX3 in liver failure patients and evaluating its potential as a diagnostic biomarker through ROC curve analysis. This evidence concerns the gene GPX3 and Hepatic failure.